Jane Street’s Achillion Pharmaceuticals ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-447,447
| Closed | -$2.7M | – | 6397 |
|
|
2019
Q4 | $2.7M | Buy |
447,447
+436,088
| +3,839% | +$2.52M | ﹤0.01% | 1623 |
|
|
2019
Q3 | $41K | Sell |
11,359
-17,914
| -61% | -$69.1K | ﹤0.01% | 4910 |
|
|
2019
Q2 | $78K | Buy |
+29,273
| New | +$86.4K | ﹤0.01% | 4898 |
|
|
2018
Q4 | – | Sell |
-26,265
| Closed | -$97K | – | 6125 |
|
|
2018
Q3 | $97K | Buy |
+26,265
| New | +$78.3K | ﹤0.01% | 4854 |
|
|
2017
Q3 | – | Sell |
-20,280
| Closed | -$93K | – | 5312 |
|
|
2017
Q2 | $93K | Buy |
20,280
+3,337
| +20% | +$13.4K | ﹤0.01% | 4173 |
|
|
2017
Q1 | $71K | Buy |
+16,943
| New | +$70.4K | ﹤0.01% | 3998 |
|
|
2016
Q2 | – | Sell |
-31,328
| Closed | -$242K | – | 4825 |
|
|
2016
Q1 | $242K | Buy |
31,328
+11,608
| +59% | +$85K | ﹤0.01% | 3469 |
|
|
2015
Q4 | $213K | Buy |
+19,720
| New | +$179K | ﹤0.01% | 3518 |
|
|
2015
Q3 | – | Sell |
-76,533
| Closed | -$678K | – | 4384 |
|
|
2015
Q2 | $678K | Buy |
+76,533
| New | +$724K | ﹤0.01% | 1983 |
|
|
2014
Q4 | – | Sell |
-30,446
| Closed | -$372K | – | 3252 |
|
|
2014
Q3 | $304K | Buy |
+30,446
| New | +$283K | ﹤0.01% | 1882 |
|
|
2014
Q1 | – | Sell |
-16,172
| Closed | -$54K | – | 3221 |
|
|
2013
Q4 | $54K | Sell |
16,172
-9,938
| -38% | -$28.8K | ﹤0.01% | 2232 |
|
|
2013
Q3 | $79K | Buy |
+26,110
| New | +$179K | ﹤0.01% | 2571 |
|
Jane Street's ACHN Position: Q1 2020 in Review
Jane Street sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 447,447 shares — an estimated $2.7M sold.
Jane Street first reported a position in ACHN in Q3 2013 and held it in 12 quarters. The position peaked at $2.7M in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.
- Jane Street reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
- Jane Street sold 447,447 Achillion Pharmaceuticals shares in Q1 2020, an estimated $2.7M.
- Jane Street first reported a position in Achillion Pharmaceuticals in Q3 2013 and held it in 12 quarters.
- Jane Street's Achillion Pharmaceuticals position peaked at $2.7M in Q4 2019.
- 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.
Based on Jane Street's 13F filing for Q1 2020, filed 15 May 2020.